(Q43199658)

15 November 2017

A model of the natural history of screen-detected prostate cancer (English)

1 reference

15 November 2017

4

1 reference

15 November 2017

C Metcalfe

1

1 reference

15 November 2017

J A Lane

series ordinal

2

1 reference

15 November 2017

F Hamdy

series ordinal

3

1 reference

15 November 2017

J L Donovan

series ordinal

5

1 reference

15 November 2017

language of work or name

English

0 references

publication date

26 September 2006

1 reference

British Journal of Cancer

15 November 2017

1 reference

15 November 2017

95

1 reference

15 November 2017

8

1 reference

15 November 2017

1122-1123

1 reference

A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival

15 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360718

Radical prostatectomy versus watchful waiting in early prostate cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360718

20-year outcomes following conservative management of clinically localized prostate cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360718

Early outcomes of active surveillance for localized prostate cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360718

Active surveillance of early prostate cancer: rationale, initial results and future developments

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360718

Results of conservative management of clinically localized prostate cancer.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360718

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360718

Prostate Testing for Cancer and Treatment (ProtecT) feasibility study

15 August 2018

2 references

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603368

21 January 2018

https://pubmed.ncbi.nlm.nih.gov/17003784

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Gleason score, age and screening: Modeling dedifferentiation in prostate cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17003784

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17003784

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/SJ.BJC.6603368

1 reference

15 November 2017

1 reference

15 November 2017

PubMed publication ID

17003784

1 reference